Only 1 variant, ATG16L1 rs78835907, showed significant association with disease progression of advanced prostate cancer after adjustment for known clinical factors (P = 0.014, Table 3 and Fig. 1B). This evidence concerns the gene ATG16L1 and prostate carcinoma.